11 |
COMPETITIVE LANDSCAPE..................................................................................................... 120 |
||
11.1 |
OVERVIEW....................................................................................................................................................................... 120 |
||
11.2 |
LEADING PLAYERS IN THE GENOME EDITING MARKET................................................................................................. 121 |
||
11.3 |
COMPETITIVE SITUATION AND TRENDS........................................................................................................................ 122 |
||
11.3.1 |
AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS.......................................................................... 123 |
||
11.3.2 |
NEW PRODUCT AND SERVICE LAUNCHES................................................................................................. 124 |
||
11.3.3 |
ACQUISITIONS............................................................................................................................................. 125 |
||
11.3.4 |
EXPANSIONS................................................................................................................................................ 126 |
||
11.3.5 |
OTHER DEVELOPMENTS.............................................................................................................................. 127 |
||
12 |
COMPANY PROFILES............................................................................................................... 128 |
12.1 |
INTRODUCTION............................................................................................................................................................... 128 |
12.2 |
THERMO FISHER SCIENTIFIC, INC................................................................................................................................. 129 |
12.3 |
HORIZON DISCOVERY GROUP PLC................................................................................................................................ 132 |
12.4 |
SIGMA-ALDRICH CORPORATION.................................................................................................................................... 135 |
12.5 |
GENSCRIPT USA INC...................................................................................................................................................... 138 |
12.6 |
SANGAMO BIOSCIENCES, INC....................................................................................................................................... 139 |
12.7 |
INTEGRATED DNA TECHNOLOGIES, INC........................................................................................................................ 141 |
12.8 |
LONZA GROUP LTD.( SWITZERLAND)............................................................................................................................. 142 |
12.9 |
NEW ENGLAND BIOLABS, INC.( U. S.)............................................................................................................................. 143 |
12.10 ORIGENE TECHNOLOGIES, INC.( U. S.)........................................................................................................................... 144 | |
12.11 TRANSPOSAGEN BIOPHARMACEUTICALS, INC.( U. S.)................................................................................................. 146 |
13 |
APPENDIX................................................................................................................................ 148 |
|
13.1 |
INSIGHTS OF INDUSTRY EXPERTS................................................................................................................................. 148 |
|
13.2 |
DISCUSSION GUIDE........................................................................................................................................................ 149 |
|
13.3 |
INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE................................................................................................ 151 |
|
13.4 |
AVAILABLE CUSTOMIZATIONS....................................................................................................................................... 152 |
|
13.5 |
RELATED REPORTS......................................................................................................................................................... 153 |